High hsCRP levels have been found to be associated with poor cardiovascular outcomes in patients with acute coronary syndrome (ACS). There are however few data and some conflicting data with regards to ST elevation MI, the full spectrum of ACS, specific subgroups of patients with ACS, and the timing of measurement of CRP. The purpose of the...

Recently, new insights have become available into how anti-inflammatory effects of statin treatment impact on what happens within the coronary arteries. As seen in the REVERSAL trial, for example, a reduction in systemic inflammation, as indicated by the level of C-reactive protein, was important in addition to cholesterol-lowering, for the...

When considering biomarkers such as LDL-C, hsCRP and HDL-C, it is of interest to know their usefulness for predicting the risk of future vascular events, and for monitoring drug effectiveness. There is data to suggest that hsCRP may be a better predictor of the risk of future cardiovascular (CV) events, such as from participants in the...

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score

This article describes how the Reynolds Risk Score was developed and validated using data from 24,558 initially healthy American women, who were followed up for a median of 10.2 years for incident cardiovascular events.

Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

New data from almost 4000 patients with ACS demonstrating the clinical utility of hs-CRP measured at 30 days or 4 months of follow-up, in terms of predicting 2-year mortality.

Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein

Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: The Cardiovascular Risk in Young Finns Study

Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension

C-Reactive Protein and Incident Left Ventricular Hypertrophy in Essential Hypertension

Health screening packages: the place of measuring C-reactive protein.

Should high sensitive C-reactive protein measurement be included in health screening packages?

Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus.

A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women

Reduced high-molecular weight adiponectin and elevated hsCRP are synergistic risk factors for metabolic syndrome in a large scale middle-aged to elderly population: the J-SHIPP study

High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome

High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation. Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis

C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease

Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984–1998

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

Obesity leads to heart-damaging inflammation, researchers find

Astrazeneca Stops Cholesterol Drug Trial Because Of Promising Results